718 related articles for article (PubMed ID: 22289875)
21. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis.
Hanafy AS; Abd-Elsalam S; Dawoud MM
Vascul Pharmacol; 2019 Feb; 113():86-91. PubMed ID: 29886103
[TBL] [Abstract][Full Text] [Related]
22. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis.
Rodriguez-Castro KI; Vitale A; Fadin M; Shalaby S; Zerbinati P; Sartori MT; Landi S; Pettinari I; Piscaglia F; Han G; Burra P; Simioni P; Senzolo M
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):34-42. PubMed ID: 30188408
[TBL] [Abstract][Full Text] [Related]
23. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
[TBL] [Abstract][Full Text] [Related]
24. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
Guerrero A; Campo LD; Piscaglia F; Scheiner B; Han G; Violi F; Ferreira CN; Téllez L; Reiberger T; Basili S; Zamora J; Albillos A;
J Hepatol; 2023 Jul; 79(1):69-78. PubMed ID: 36858157
[TBL] [Abstract][Full Text] [Related]
25. Portal vein thrombosis: yes or no on anticoagulation therapy.
Turon F; Hernández-Gea V; García-Pagán JC
Curr Opin Organ Transplant; 2018 Apr; 23(2):250-256. PubMed ID: 29432256
[TBL] [Abstract][Full Text] [Related]
26. Portal vein thrombosis; risk factors, clinical presentation and treatment.
Sogaard KK; Astrup LB; Vilstrup H; Gronbaek H
BMC Gastroenterol; 2007 Aug; 7():34. PubMed ID: 17697371
[TBL] [Abstract][Full Text] [Related]
27. Impact of anticoagulation on outcomes in acute non-cirrhotic and non- malignant portal vein thrombosis: a retrospective observational study.
Hall TC; Garcea G; Metcalfe M; Bilk D; Rajesh A; Dennison A
Hepatogastroenterology; 2013; 60(122):311-7. PubMed ID: 23858545
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis.
Zhou H; Wu M; Yu S; Xia H; Yu W; Huang K; Chen Y
BMC Gastroenterol; 2023 Sep; 23(1):329. PubMed ID: 37749527
[TBL] [Abstract][Full Text] [Related]
29. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study.
Plessier A; Darwish-Murad S; Hernandez-Guerra M; Consigny Y; Fabris F; Trebicka J; Heller J; Morard I; Lasser L; Langlet P; Denninger MH; Vidaud D; Condat B; Hadengue A; Primignani M; Garcia-Pagan JC; Janssen HL; Valla D;
Hepatology; 2010 Jan; 51(1):210-8. PubMed ID: 19821530
[TBL] [Abstract][Full Text] [Related]
30. Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.
Scheiner B; Stammet PR; Pokorny S; Bucsics T; Schwabl P; Brichta A; Thaler J; Lampichler K; Ba-Ssalamah A; Ay C; Ferlitsch A; Trauner M; Mandorfer M; Reiberger T
Wien Klin Wochenschr; 2018 Jul; 130(13-14):446-455. PubMed ID: 29916054
[TBL] [Abstract][Full Text] [Related]
31. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
[TBL] [Abstract][Full Text] [Related]
32. Early prophylactic anticoagulation via transjugular intrahepatic route for portal vein thrombosis after splenectomy in cirrhotic portal hypertension.
Yang S; He C; Fan X; Ding W; Wu X; Li J
J Vasc Interv Radiol; 2015 Jul; 26(7):1009-17. PubMed ID: 25921970
[TBL] [Abstract][Full Text] [Related]
33. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.
Chung JW; Kim GH; Lee JH; Ok KS; Jang ES; Jeong SH; Kim JW
Clin Mol Hepatol; 2014 Dec; 20(4):384-91. PubMed ID: 25548745
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis.
Koh JH; Liew ZH; Ng GK; Liu HT; Tam YC; De Gottardi A; Wong YJ
Dig Liver Dis; 2022 Jan; 54(1):56-62. PubMed ID: 34393072
[TBL] [Abstract][Full Text] [Related]
35. Is Post-TIPS Anticoagulation Therapy Necessary in Patients with Cirrhosis and Portal Vein Thrombosis? A Randomized Controlled Trial.
Wang Z; Jiang MS; Zhang HL; Weng NN; Luo XF; Li X; Yang L
Radiology; 2016 Jun; 279(3):943-51. PubMed ID: 26653681
[TBL] [Abstract][Full Text] [Related]
36. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism.
Kawanaka H; Akahoshi T; Kinjo N; Konishi K; Yoshida D; Anegawa G; Yamaguchi S; Uehara H; Hashimoto N; Tsutsumi N; Tomikawa M; Maehara Y
Ann Surg; 2010 Jan; 251(1):76-83. PubMed ID: 19864937
[TBL] [Abstract][Full Text] [Related]
37. Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban.
Yang H; Kim SR; Song MJ
Clin Mol Hepatol; 2016 Dec; 22(4):499-502. PubMed ID: 27880998
[TBL] [Abstract][Full Text] [Related]
38. Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis.
Chun HS; Choe AR; Lee M; Cho Y; Kim HY; Yoo K; Kim TH
Clin Mol Hepatol; 2021 Oct; 27(4):535-552. PubMed ID: 34130370
[TBL] [Abstract][Full Text] [Related]
39. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate.
Faccia M; Ainora ME; Ponziani FR; Riccardi L; Garcovich M; Gasbarrini A; Pompili M; Zocco MA
World J Gastroenterol; 2019 Aug; 25(31):4437-4451. PubMed ID: 31496623
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis.
Ai MH; Dong WG; Tan XP; Xu L; Xu C; Zhang Q; Zhang Y; Li J
Eur J Gastroenterol Hepatol; 2020 Oct; 32(10):1395-1400. PubMed ID: 32675774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
